top of page
Search

GLP-1 vs GLP-2 vs GLP-3 Weight-Loss Medications. Whats the difference?

Mar 5
4 min read

Updated: Mar 12

Semaglutide vs Tirzepatide vs Retatrutide Explained

GLP's: What's the difference? Weight-loss medications have rapidly evolved over the past few years, transforming how obesity and metabolic disease are treated. Drugs that target hormones controlling appetite, insulin, and metabolism are producing results once only achievable through bariatric surgery.

The most talked-about medications today are semaglutide, tirzepatide, and retatrutide. Many people refer to them as GLP-1, GLP-2, and GLP-3 medications, reflecting how each new generation targets more metabolic pathways.

But what's the difference between these drugs—and which one is best for your weight-loss goals?

This guide explains how each medication works, how effective they are, and how to choose the best option for your needs.



What Are GLP-1 Weight Loss Medications?

GLP-1 medications mimic a natural hormone called glucagon-like peptide-1, which plays an important role in regulating appetite, digestion, and blood sugar.

These medications help people lose weight by:

  • Reducing hunger signals in the brain

  • Slowing stomach emptying to increase fullness

  • Improving insulin sensitivity

  • Stabilizing blood sugar levels

Over time, pharmaceutical research expanded on this idea by targeting multiple hormones instead of just GLP-1, which is how newer drugs like tirzepatide and retatrutide were developed.


Illustration showing the mechanisms by which weight loss is achieved


GLP-1 Medications: Semaglutide


Semaglutide was the first major breakthrough medication for medical weight loss and remains one of the most widely prescribed options today.


How semaglutide works

Semaglutide mimics the GLP-1 hormone, which signals the brain that you are full and satisfied after eating. This helps reduce overall calorie intake while improving blood sugar control.


Average weight loss with semaglutide

Clinical trials show patients typically lose:

12–15% of their total body weight

For someone weighing 220 pounds, that could mean losing 25–35 pounds over about 12–16 months.


Benefits

  • Proven long-term safety data

  • FDA-approved for obesity treatment

  • Effective appetite suppression


Potential side effects

  • Nausea

  • Constipation

  • Acid reflux

  • Temporary fatigue


Best for

Semaglutide is often ideal for:

  • First-time medical weight-loss patients

  • Moderate weight loss goals (20–40 lbs)

  • People who want a medication with established long-term data


GLP-2 (Dual Hormone) Medications: Tirzepatide


Tirzepatide represents the next generation of metabolic medications because it activates two hormones instead of one.


Hormones targeted

Tirzepatide activates both:

  • GLP-1 – appetite suppression

  • GIP (glucose-dependent insulinotropic polypeptide) – improves insulin sensitivity and metabolic efficiency

This dual-hormone effect produces stronger weight loss results than GLP-1 medications alone.


Average weight loss with tirzepatide

Clinical trials show patients lose:

18–22% of their total body weight

Some participants lost over 25% of body weight, which begins to approach results seen with bariatric surgery.


Benefits

  • Greater weight loss than semaglutide

  • Strong improvements in insulin resistance

  • Reduced cravings and hunger

  • Effective for type 2 diabetes and obesity


Potential side effects

  • Nausea

  • Digestive discomfort

  • Appetite suppression that may feel intense initially


Best for

Tirzepatide is often recommended for:

  • Patients needing significant weight loss (40–100+ pounds)

  • People who plateaued on semaglutide

  • Patients with insulin resistance or type 2 diabetes


GLP-3 (Triple Hormone) Medications: Retatrutide


Retatrutide is the newest and most powerful weight-loss medication currently under development.

Unlike earlier drugs, retatrutide activates three metabolic hormones simultaneously.


Hormones targeted

Retatrutide stimulates:

  • GLP-1 → reduces appetite

  • GIP → improves insulin response

  • Glucagon receptor → increases energy expenditure and fat burning

This triple-hormone combination affects both hunger and metabolism, which may explain the dramatic weight-loss results seen in early trials.


Average weight loss with retatrutide

Early clinical studies show:

24–30% body weight reduction

These results are comparable to some forms of bariatric surgery.


Benefits

  • Largest weight loss seen in medication trials

  • May increase metabolic rate

  • Potential improvement in fatty liver disease and metabolic health


Current limitations

  • Still in clinical trials

  • Long-term safety data still developing


Best for

Retatrutide may become the preferred option for:

  • Severe obesity

  • Patients needing surgical-level weight loss

  • Individuals seeking maximum metabolic improvement


Semaglutide vs Tirzepatide vs Retatrutide Comparison

Medication

Hormones Targeted

Average Weight Loss

Status

Semaglutide

GLP-1

12–15%

FDA approved

Tirzepatide

GLP-1 + GIP

18–22%

FDA approved

Retatrutide

GLP-1 + GIP + Glucagon

24–30%

Clinical trials


Which GLP Medication Is Best.

Best for moderate weight loss

Semaglutide

Ideal for individuals looking to lose 20–40 pounds with a medication that has extensive safety data.


Best for significant weight loss

Tirzepatide

Often recommended for patients needing 40–100 pounds of weight loss or those with metabolic conditions like insulin resistance.


Best for maximum weight loss

Retatrutide (future option)

Early studies suggest retatrutide may become the most powerful obesity medication available.


The Future of Medical Weight Loss

The development of hormone-based obesity medications has changed how doctors approach weight management.

Instead of relying solely on diet and exercise, physicians can now address the biological drivers of hunger, metabolism, and insulin resistance.

These medications are rapidly improving, and future therapies may continue to build on this hormone-targeting approach.

For many people struggling with weight loss, these treatments represent one of the most promising medical advances in decades.



The statements and information presented on this website and blog have not been evaluated by the U.S. Food and Drug Administration (FDA). The content provided is for informational and educational purposes only and products on our site are for research use only.


By purchasing or using products from this site, you acknowledge that the products are not intended for human use and agree to use them only for lawful research purposes. The purchaser assumes full responsibility for the proper handling and use of all products purchased from this website.


The information contained within this blog and website is not intended to replace professional medical advice. Our products are not intended to diagnose, treat, prevent or cure any disease or medical condition. Always consult a qualified healthcare professional regarding any medical condition or health-related concerns.

 
 
 

Recent Posts

See All

Comments


bottom of page